Latent tuberculosis infection amongst patients with rheumatic diseases in an Irish tertiary referral centre – A five-year review

Published:October 27, 2021DOI:
      To the editor,


      To read this article in full you will need to make a payment


      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kiazyk S.
        • Ball T.B.
        Latent tuberculosis infection: an overview.
        Can Commun Dis Rep. 2017; 43 (Published 2017 Mar 2.): 62-66
      1. Guidelines on the Prevention and Control of Tuberculosis 2010 (amended 2014), Health Protection Surveillance Centre.,4349,en.pdf (Amended 2014).

        • Martin J.
        • Walsh C.
        • Gibbs A.
        • McDonnell T.
        • Fearon U.
        • Keane J.
        Comparison of interferon-gamma release assays and conventional screening tests before tumour necrosis factor-alpha blockade in patients with inflammatory arthritis.
        Ann Rheum Dis. 2010; 69: 181-185
        • Bélard E.
        • Semb S.
        • Ruhwald M.
        • et al.
        Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.
        Inflamm Bowel Dis. 2011; 17 (Novdoi): 2340-2349 2011 Feb 11. PMID: 21319275
        • Anton C.
        • Machado F.D.
        • Ramirez J.
        • et al.
        Latent tuberculosis infection in patients with rheumatic diseases.
        J Bras Pneumol. 2019; 45e20190023
      2. List of Notifiable Diseases - Health Protection Surveillance Centre [Internet]. 2020 [cited 15 September 2021]. Available from: